Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH)

Historical Holders from Q3 2023 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value
Symbol
DNTH on Nasdaq
Shares outstanding
43,666,020
Price per share
$41.21
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
46,828,772
Total reported value
$1,842,663,442
% of total 13F portfolios
0.01%
Share change
+7,737,001
Value change
+$358,133,968
Number of holders
140
Price from insider filings
$41.21
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +7.1% $234,944,605 +$58,553,941 5,970,638 +33% FMR LLC 30 Sep 2025
RA CAPITAL MANAGEMENT, L.P. 9.5% +6.7% $152,155,944 +$39,350,000 3,866,733 +35% RA Capital Management, L.P. 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP 6.5% $101,431,000 2,577,662 Wellington Management Group LLP 30 Sep 2025
Octagon Capital Advisors LP 6.1% -14% $95,095,846 +$12,060,775 2,416,667 +15% Octagon Capital Advisors LP 30 Sep 2025
Fairmount Funds Management LLC 4.9% -50% $72,191,285 -$64,524,950 2,139,635 -47% Fairmount Funds Management LLC 21 Nov 2025
Point72 Asset Management, L.P. 5.3% +16% $44,225,769 +$14,080,318 2,121,140 +47% Point72 Asset Management, L.P. 11 Sep 2025
Avidity Partners Management LP 4.9% -50% $70,995,168 -$43,010,234 2,104,184 -38% Avidity Partners Management LP 17 Nov 2025
BlackRock, Inc. 5% $34,803,328 1,600,153 BlackRock, Inc. 31 Mar 2025
TCG Crossover GP II, LLC 4.7% $32,660,322 1,501,624 TCG Crossover GP II, LLC 31 Mar 2025
BCLS Fund III Investments, LP 3.1% -55% $51,780,350 -$45,896,187 1,315,892 -47% BCLS Fund III Investments, LP 30 Sep 2025
Vestal Point Capital, LP 3% -70% $46,433,000 -$79,487,000 1,180,000 -63% Vestal Point Capital, LP 30 Sep 2025
Venrock Healthcare Capital Partners III, L.P. 3.1% $20,060,000 1,000,000 Venrock Healthcare Capital Partners III, L.P. 30 Jun 2025
As of 30 Sep 2025, Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH) has 140 institutional shareholders filing 13F forms. They hold 46,828,772 shares. .

Top 25 institutional shareholders own 89% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
FMR LLC 14% 5,970,638 +31% 0.01% $234,944,606
Fairmount Funds Management LLC 7.6% 3,307,191 +22% 12% $130,137,966
Avidity Partners Management LP 7.3% 3,204,184 +84% 29% $126,084,640
RA CAPITAL MANAGEMENT, L.P. 6.6% 2,866,733 0% 1.4% $112,805,944
WELLINGTON MANAGEMENT GROUP LLP 5.9% 2,577,662 +3367% 0.02% $101,430,999
Octagon Capital Advisors LP 5.5% 2,416,667 +3.2% 15% $95,095,846
Point72 Asset Management, L.P. 4.7% 2,041,960 +47% 0.17% $80,351,150
TCG Crossover Management, LLC 3.8% 1,676,624 +12% 3.2% $65,975,154
VANGUARD GROUP INC 3.8% 1,642,198 +14% 0% $64,620,492
BlackRock, Inc. 3.1% 1,340,091 -1.4% 0% $52,732,580
Bain Capital Life Sciences Investors, LLC 3% 1,315,892 -47% 3.4% $51,780,350
Vestal Point Capital, LP 2.7% 1,180,000 -63% 2.1% $46,433,000
CITADEL ADVISORS LLC 2.3% 1,013,501 +52% 0.03% $39,881,264
VR ADVISER, LLC 2.2% 960,803 -3.9% 2.1% $37,807,598
ALLIANCEBERNSTEIN L.P. 2% 852,384 -27% 0.01% $33,541,310
BRAIDWELL LP 1.9% 835,057 0.97% $32,859,493
BAKER BROS. ADVISORS LP 1.8% 789,759 0% 0.22% $31,077,017
Polar Capital Holdings Plc 1.7% 748,003 0.14% $29,433,918
SILVERARC CAPITAL MANAGEMENT, LLC 1.5% 674,966 +605% 3.8% $26,559,912
STATE STREET CORP 1.5% 671,048 -18% 0% $26,405,739
Catalio Capital Management, LP 1.5% 667,615 -11% 4.9% $26,270,650
Sio Capital Management, LLC 1.3% 577,750 +145% 5.8% $22,734,463
MARSHALL WACE, LLP 1.3% 572,938 0.02% $22,545,109
GEODE CAPITAL MANAGEMENT, LLC 1.2% 536,415 +11% 0% $21,113,062
FRANKLIN RESOURCES INC 1% 450,311 0% $17,719,737

Institutional Holders of Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 18,799 $774,643 +$766,607 $41.21 2
2025 Q3 46,828,772 $1,842,663,442 +$358,133,968 $39.35 140
2025 Q2 39,106,709 $728,558,630 +$24,440,177 $18.63 101
2025 Q1 37,715,319 $685,461,303 +$43,246,773 $18.14 97
2024 Q4 35,126,689 $765,706,199 +$63,092,353 $21.80 94
2024 Q3 31,364,805 $858,714,506 +$44,837,092 $27.38 90
2024 Q2 29,702,499 $768,778,734 +$87,583,327 $25.88 74
2024 Q1 26,075,021 $782,250,559 +$479,966,613 $30.00 75
2023 Q4 10,291,119 $106,507,945 +$518,588 $10.40 38
2023 Q3 10,072,640 $136,328,208 +$136,328,208 $13.67 30